Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,555.00    160.00 (2.50%)
Bid:
6,545.00
Ask:
6,550.00
Spread: 5.00 (0.076%)
Market Cap: £4.84b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Directorate Change

10 Feb 2009 12:37

RNS Number : 0867N
Spirax-Sarco Engineering PLC
10 February 2009
 



10th February 2009

STOCK EXCHANGE ANNOUNCEMENT

BOARD CHANGES AT SPIRAX-SARCO ENGINEERING PLC

The Board of Directors of Spirax-Sarco Engineering plc announces the following changes in the Board to take account of retirements and changing roles. These changes are designed to continue to strengthen the Board and support the development of the Group's successful businesses. Spirax Sarco is the world leader in providing engineered solutions for the steam-using and peristaltic pump markets.

Dr Krishnamurthy Rajagopal (age 55) is appointed as an independent non-executive director with effect from 10th Febrary 2009, replacing Einar Lindh whose retirement on 31st December 2008 was announced previously. Dr Rajagopal was previously a main board director of BOC Group plc and Chief Executive of BOC Edwards.

Dr Rajagopal is currently a non-executive director of Dyson Group plc, WS Atkins plc and Bodycote plc. He is also an Audit Commissioner. Until April 2008 he was a non-executive director of Foseco plc. He is a member of the Council for Science and Technology, the Prime Ministerial advisory body, and a Member of the Advisory Board of the Centre for Business Research at Cambridge University. Dr Rajagopal will join the Audit, Remuneration and Nomination Committees and we look forward to his making a strong contribution to the Board.

Alan Black will be leaving the Board on 30th April 2009 realising his long-held intention to retire early. Alan started work at Spirax in 1981 and came onto the Board in 1998. During his long career at Spirax, Alan has been responsible for many of the Group's operating companies in Asia and Europe, and is currently responsible for the company's steam business in Asia, the UK/ROI and South America. Alan has helped to develop those businesses and we thank him for much of the growth and development in those markets in recent years.

We welcome Michael Gibbin (age 46) to the Board from 1st May 2009 as an executive director with responsibility for the company's manufacturing operations in Cheltenham and Châtellerault, France, the company's steam business operations in North America, Cheltenham-based product development and Group-wide health & safety. Mike joined Spirax in 2007 responsible for the Group's manufacturing operations in Cheltenham. He brings previous relevant experience in new product development, manufacturing and general management from the automotive industry, working previously as Chief Executive of Comau Sweden (Fiat) and senior engineering manager for Honda. Mike graduated in mechanical engineering and is a chartered engineer. We look forward to him making a strong contribution to the future development of the Group.

In connection with Mike's appointment, Tony Scrivin will assume responsibility for the company's steam business operations in the UK, Europe and Africa, and Neil Daws will assume responsibility for the company's steam business in the Asia Pacific region and South America.

There are no further disclosures to be made pursuant to Listing Rule 9.6.13.

Enquiries:

Mark E Vernon

Chief Executive

Mike Townsend

Chairman

Spirax-Sarco Engineering plc

Charlton House

Cheltenham, Glos.

GL53 8ER

Tel: 01242 521361

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABDGDDSXBGGCG
Date   Source Headline
1st Jul 201011:15 amRNSTotal Voting Rights
17th Jun 201010:01 amRNSDirector Declaration
15th Jun 20102:48 pmRNSNotice of Results
8th Jun 20104:13 pmRNSDirector/PDMR Shareholding
4th Jun 20102:17 pmRNSHolding(s) in Company
1st Jun 20101:34 pmRNSTotal Voting Rights
28th May 20103:20 pmRNSDirector/PDMR Shareholding
25th May 20101:30 pmRNSAcquisition
21st May 20104:56 pmRNSDirector/PDMR Shareholding
14th May 20104:01 pmRNSDirector/PDMR Shareholding
14th May 201011:06 amRNSAGM Statement
11th May 20105:16 pmRNSDirector/PDMR Shareholding
11th May 20105:13 pmRNSAGM Statement
11th May 20101:00 pmRNSInterim Management Statement
4th May 201011:29 amRNSTotal Voting Rights
14th Apr 20104:04 pmRNSHolding(s) in Company
1st Apr 20109:13 amRNSTotal Voting Rights
29th Mar 20104:20 pmRNSDirector/PDMR Shareholding
29th Mar 20104:17 pmRNSHolding(s) in Company
25th Mar 201011:40 amRNSAnnual Financial Report
10th Mar 20104:21 pmRNSDirector/PDMR Shareholding
9th Mar 20105:16 pmRNSDirector/PDMR Shareholding
8th Mar 20106:15 pmRNSDirector/PDMR Shareholding
5th Mar 20104:18 pmRNSDirector/PDMR Shareholding
4th Mar 20107:00 amRNS2009 Preliminary Results
1st Mar 20106:07 pmRNSTotal Voting Rights
1st Feb 201011:13 amRNSTotal Voting Rights
1st Feb 201011:10 amRNSTotal Voting Rights - Replacement
18th Jan 20109:17 amRNSNotice of Results
8th Jan 20107:00 amRNSTrading Update
4th Jan 201010:36 amRNSTotal Voting Rights
4th Dec 20092:35 pmRNSHolding(s) in Company
1st Dec 20094:41 pmRNSDirector/PDMR Shareholding - Replacement
1st Dec 20093:58 pmRNSTotal Voting Rights
1st Dec 20093:56 pmRNSDirector/PDMR Shareholding
26th Nov 20091:49 pmRNSDirector Declaration
9th Nov 20093:42 pmRNSDirector/PDMR Shareholding
9th Nov 20097:00 amRNSInterim Management Statement
2nd Nov 20098:37 amRNSTotal Voting Rights
9th Oct 20093:21 pmRNSDirector/PDMR Shareholding
6th Oct 200912:34 pmRNSHolding(s) in Company
2nd Oct 20092:08 pmRNSHolding(s) in Company
2nd Oct 20098:30 amRNSAcquisition
1st Oct 200911:56 amRNSTotal Voting Rights
29th Sep 20094:29 pmRNSDirector/PDMR Shareholding
24th Sep 20091:49 pmRNSDirector/PDMR Shareholding
4th Sep 20092:24 pmRNSTotal Voting Rights
27th Aug 20093:32 pmRNSAcquisition
20th Aug 20097:00 amRNS2009 Half Year Results
5th Aug 20092:07 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.